TAMC

TAMC is a standardized microbiological test used to evaluate the quality of non-sterile products, such as research chemicals and synthesized peptides. It identifies visible microbial growth and reports results as Colony-Forming Units (CFU) per gram or milliliter to show the level of contamination in a product.

TAMC testing process and microbiological limits

In a TAMC test, a sample is incubated on a growth medium in an oxygen-rich environment at 30-35°C. Visible clusters of microorganisms, called colonies, are then counted and reported as CFU. This measurement allows you to see if a product stays within accepted microbiological safety limits.

Acceptance limits vary depending on the product type. Non-sterile pharmaceutical raw materials typically have a limit of 1,000 CFU/g, while finished products may have stricter requirements down to 100 CFU/g. A high TAMC value often indicates poor manufacturing hygiene, contamination during synthesis, or incorrect storage.

Common interpretation mistakes for TAMC results

• Confusing TAMC with TYMC: TAMC measures general bacteria, whereas TYMC (Total Combined Yeasts and Molds Count) specifically targets fungi.
• Purity vs. Safety: An HPLC purity of 99% refers only to chemical purity. It does not reflect microbiological safety, which is measured by TAMC.
• Pathogens and Endotoxins: TAMC provides a total count but does not identify specific dangerous pathogens or measure endotoxins (toxic bacterial fragments). Specific pathogens require separate tests like USP <62>.

Sources

1. Beyond Efficacy: Ensuring Safety in Peptide Therapeutics ...
2. Microbiological Quality Considerations in Non-sterile Drug Manufacturing
3. Biotechnology Inspection Guide (11/91) | FDA
4. ANDAs for Certain Highly Purified Synthetic Peptide
5. Microbiological quality of non-sterile pharmaceutical products
6. Microbiological Quality of Selected Local and Imported Non ...
7. Microbiological Contamination of Medicinal Products - PMC
8. The FDA Peptide Regulations Explained: What's Legal, What's Not, and What's Coming
9. Research Peptides & FDA Regulations 2026 | Artemis Labs - Artemis Labs
10. Slide 1
11. Clinical Pharmacology Considerations for Peptide Drug Products | FDA
12. the Synthetic Peptide Guidance and PSGs
13. USP Microbial Enumeration Tests for Nonsterile Products
14. USP 61: Microbiological Examination of Nonsterile Products
15. Microbial Limits: USP 61/62 Testing Guide (May 2026)
16. <61> MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS
17. [PDF] 1111 MICROBIOLOGICAL EXAMINATION OF NONSTERILE ... - USP
18. News and Events | TAMC, TYMC, and absence test for personal care products, pharmaceuticals, cosmetics, and other products categorized as non-sterile. Blog post by Sneha Mistry